GARDEN CITY, New York-Heritage New York Medical Group, part of Heritage Medical Systems, is offering physicians interactive health-monitoring devices as part of an expanded disease management program.
The devices target patients with chronic diseases such as asthma, diabetes, and heart disease. Upon receipt of their device, patients connect the wireless unit to a normal telephone line. The unit, about the size of a paperback book, has large response buttons, which patients use daily to answer health status questions. Their answers are complied and posted on a secure Web site for review by the patients' physicians.
In return, doctors can send their patients reminders, feedback, and tips for disease management. Based on answers to health status questions, patients can be monitored for rapid intervention if necessary.
The system is expected to reduce paperwork and allows physicians to have a daily report on the status of their patients.
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.